From the Pfizer Ltd, Tadworth, United Kingdom (L.A., R.R., L.S.-R.); Pfizer Inc, New York, NY (B.E.); Rolls-Royce PLC, Derby, United Kingdom (affiliation for David Roomes under which the work was done) (D.R., K.G.); Bristol Myers Squibb, Chester, United Kingdom (current affiliation for David Roomes) (D.R.); Adelphi Real World, Bollington, United Kingdom (G.T.-S., L.M., H.W.); and Centre for Applied Research in Health, University of Huddersfield, Huddersfield, United Kingdom (K.B.).
J Occup Environ Med. 2023 Jun 1;65(6):e424-e434. doi: 10.1097/JOM.0000000000002845. Epub 2023 Mar 25.
We aimed to investigate the burden of persistent musculoskeletal (MSK) pain in Rolls-Royce UK employees.
Employees with ( n = 298) and without ( n = 329) persistent MSK pain completed a cross-sectional survey. Weighted regression analyses were conducted to compare sickness absence, work ability, workplace accommodations/adaptations, and emotional well-being between these cohorts, controlling for confounders.
Persistent MSK pain (particularly back pain) had a significant impact on physical work ability and was associated with increased sickness absence due to pain. Many employees (56%) had not disclosed their condition to their managers. Of these, 30% felt uncomfortable doing so, and 19% of employees reported insufficient support at work for their pain.
These findings highlight the importance of creating a workplace culture that encourages the disclosure of work-relevant pain, enabling organizations to consider improved, tailored support for employees.
我们旨在调查罗尔斯·罗伊斯英国员工持续性肌肉骨骼（MSK）疼痛的负担。
患有（n=298）和不患有（n=329）持续性 MSK 疼痛的员工完成了一项横断面调查。进行加权回归分析，以比较这些队列的病假、工作能力、工作场所适应和情绪健康状况，同时控制混杂因素。
持续性 MSK 疼痛（尤其是背痛）对身体工作能力有重大影响，并与因疼痛导致的病假增加有关。许多员工（56%）没有向经理披露他们的病情。其中，30%的人对此感到不舒服，19%的员工报告说他们的疼痛在工作中没有得到足够的支持。
这些发现强调了创造一种鼓励披露与工作相关疼痛的工作场所文化的重要性，使组织能够考虑为员工提供更好、更有针对性的支持。
